The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Karbal, Renu
    Director born in November 1962
    Individual (4 offsprings)
    Officer
    2023-09-03 ~ now
    OF - Director → CIF 0
  • 2
    Karbal, Bharat Bhushan, Dr
    Company Director born in January 1961
    Individual (6 offsprings)
    Officer
    2021-09-02 ~ now
    OF - Director → CIF 0
    Dr Bharat Bhushan Karbal
    Born in January 1961
    Individual (6 offsprings)
    Person with significant control
    2021-09-02 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 1
  • Ms Renu Karbal
    Born in November 1961
    Individual (4 offsprings)
    Person with significant control
    2021-11-29 ~ 2025-01-29
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

MEDICAL PHARMA PROJECTS LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
21,010 GBP2024-09-30
25,626 GBP2023-09-30
Debtors
20,038 GBP2024-09-30
29,498 GBP2023-09-30
Cash at bank and in hand
184,093 GBP2024-09-30
175,593 GBP2023-09-30
Current Assets
204,131 GBP2024-09-30
205,091 GBP2023-09-30
Net Current Assets/Liabilities
179,661 GBP2024-09-30
165,593 GBP2023-09-30
Total Assets Less Current Liabilities
200,671 GBP2024-09-30
191,219 GBP2023-09-30
Creditors
Amounts falling due after one year
-17,604 GBP2024-09-30
-21,205 GBP2023-09-30
Net Assets/Liabilities
179,075 GBP2024-09-30
164,376 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
475 GBP2024-09-30
475 GBP2023-09-30
Motor vehicles
35,250 GBP2024-09-30
35,250 GBP2023-09-30
Computers
5,620 GBP2024-09-30
4,484 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
41,345 GBP2024-09-30
40,209 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
357 GBP2024-09-30
238 GBP2023-09-30
Motor vehicles
17,202 GBP2024-09-30
12,690 GBP2023-09-30
Computers
2,776 GBP2024-09-30
1,655 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
20,335 GBP2024-09-30
14,583 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
119 GBP2023-10-01 ~ 2024-09-30
Motor vehicles
4,512 GBP2023-10-01 ~ 2024-09-30
Computers
1,121 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
5,752 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment
Plant and equipment
118 GBP2024-09-30
237 GBP2023-09-30
Motor vehicles
18,048 GBP2024-09-30
22,560 GBP2023-09-30
Computers
2,844 GBP2024-09-30
2,829 GBP2023-09-30
Prepayments/Accrued Income
Amounts falling due within one year
13,830 GBP2024-09-30
24,986 GBP2023-09-30
Other Debtors
Amounts falling due within one year
6,208 GBP2024-09-30
4,512 GBP2023-09-30
Debtors
Amounts falling due within one year
20,038 GBP2024-09-30
29,498 GBP2023-09-30
Finance Lease Liabilities - Total Present Value
Amounts falling due within one year
3,602 GBP2024-09-30
3,750 GBP2023-09-30
Taxation/Social Security Payable
Amounts falling due within one year
19,718 GBP2024-09-30
30,005 GBP2023-09-30
Loans received from directors
Amounts falling due within one year
3,843 GBP2023-09-30
Accrued Liabilities
Amounts falling due within one year
1,150 GBP2024-09-30
1,900 GBP2023-09-30
Finance Lease Liabilities - Total Present Value
Amounts falling due after one year
17,604 GBP2024-09-30
21,205 GBP2023-09-30
Number of shares allotted
Class 1 ordinary share
100 shares2023-10-01 ~ 2024-09-30
Par Value of Share
Class 1 ordinary share
1 GBP2023-10-01 ~ 2024-09-30
Nominal value of allotted share capital
Class 1 ordinary share
100 GBP2023-10-01 ~ 2024-09-30
100 GBP2022-10-01 ~ 2023-09-30
Advances or credits given to directors
6,206 GBP2024-09-30
4,512 GBP2023-09-30
Advances or credits made to directors during the period
33,236 GBP2023-10-01 ~ 2024-09-30
Advances or credits repaid by directors
31,541 GBP2023-10-01 ~ 2024-09-30
Average Number of Employees
22023-10-01 ~ 2024-09-30
12022-10-01 ~ 2023-09-30
  • MEDICAL PHARMA PROJECTS LIMITED
    Info
    Registered number 13600107
    Lawrence House 5, St. Andrews Hill, Norwich, Norfolk NR2 1AD
    Private Limited Company incorporated on 2021-09-02 (3 years 9 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2025-03-05
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.